Medrobotics Appoints Richard S. Walsh Vice-President Global Sales

Company Prepares for Commercialization of the Ground-Breaking Flex™ System in Otolaryngology

 

FOR IMMEDIATE RELEASE
Contact: Diane Wilson (978) 656-1258

RAYNHAM, Mass., Feb. 4, 2013 — Medrobotics Corp., an emerging medical robotics company developing the innovative Flex™ System, announced the appointment of Richard S. Walsh as Vice-President Global Sales today.  The appointment coincides with Medrobotics’ anticipated commercial launches in Europe and the United States.

“We are delighted to have Richard join our growing company,” said Samuel Straface, Ph.D., president and CEO of Medrobotics. “He brings extensive experience in building highly-trained sales teams and driving early adoption of cutting-edge surgical systems, including robotics and ENT devices.” Under Mr. Walsh’s sales leadership over the next several months the company will be preparing for commercialization of the Flex System, a platform to provide minimally invasive transoral access and visualization for surgery in hard-to-reach locations in the throat and voice box.

Prior to joining Medrobotics, Mr. Walsh was Vice President of Sales for NeoTract, Inc., a novel urology surgical device company.  Mr. Walsh previously held executive sales positions at Acclarent, where he helped develop the US and international minimally invasive balloon sinuplasty marketplace and led the organization in revenue growth for four years.  Prior to Acclarent, Mr. Walsh held executive positions at Atricure, Stereotaxis, and Intuitive Surgical during the early commercialization of the DaVinci surgical robot.  “I am very excited to be part of the Medrobotics team,” said Mr. Walsh.  “Over the course of my career, I have been fortunate to have worked for some of the world’s most innovative medical device companies, and I believe Medrobotics is one of them.” 

The Flex System is anticipated to provide a cost‐effective, robot-assisted surgical platform for hospitals and surgeons eager to expand their offering of minimally-invasive treatment options. Minimally-invasive surgery has been shown to be more cost-effective and less painful for the patient and leads to quicker hospital discharge and faster recovery.  “I look forward to introducing our leading-edge products to hospitals and surgical teams worldwide so they and their patients can benefit from the technology,” said Mr. Walsh.

About Medrobotics

Medrobotics Corporation (www.Medrobotics.com) is a privately-held company headquartered in Raynham, Massachusetts that is developing and commercializing the Flex System, a robotic-assist platform that enables surgeons to gain single-site access and visualization to difficult-to-access anatomical locations. The system provides a precise and stable platform for enhanced visualization and enables two-handed dexterity with compatible third-party instruments having tactile feedback.

 

Medrobotics Announces Launch of the Flex® Retractor More

Surgeons Complete Cancer Surgery with Medrobotics’ Flex® System in Front of a Live Audience at Head and Neck Surgical Course at University Hospital of Marburg More

Surgeons of the University Hospital Essen Complete World’s First Robotic-Assisted Cancer Surgery with Medrobotics' Flex® System More

University Hospital Dinant Godinne-UCL Namur Completes World’s First Robotic-Assisted Surgery with Medrobotics‘ Flex® System More

Medrobotics Closes $26 Million Series E Financing More

Medrobotics Corporation Receives CE Mark for the Flex® System, Mar. 18, 2014, More

Medrobotics Appoints Russell M. Singleton, Ph.D., as Senior Vice-President R&D, Mar. 17, 2014 More

Medrobotics Appoints Thomas F. Patzelt Vice-President Marketing, Jan. 2, 2014 More

Medrobotics Gains ISO 13485: 2003 Certification for the Design, Manufacture, Service and Distribution of the Flex™ System, Nov. 3, 2013 More

Medrobotics Closes On $10 Million Financing From Hercules, March 22, 2013 More

Medrobotics Appoints Richard S. Walsh Vice-President Global Sales, Feb. 4, 2013 More

Medrobotics Completes $33.6 Million Series D Financing: Company Prepares for Commercialization of the Ground-Breaking Flex™ System in Otolaryngology, Dec. 20, 2012
More

Medrobotics Corporation. ©2014. All rights reserved.   Legal Information  •  Privacy Policy